Embedded Files
NANOMATERIALS FOR ENHANCED THERAPEUTICS
Conventional drug delivery systems often struggle with low payload efficiency limited cellular uptake and poor control over distribution at the target site. This creates a need for materials that can improve how therapeutic agents are carried and delivered at the nanoscale
NANOARC specialises in the manufacture and supply of ultra-small, ligand-free nanomaterials with exceptionally high surface area (SSA), designed to enhance drug delivery, therapeutic loading, and treatment precision. Our nanoparticles act as a platform for researchers and pharmaceutical developers to increase the effectiveness of drugs while minimising side effects.
High SSA is critical in nanotherapeutics. The larger the surface area, the more therapeutic molecules can be loaded onto each particle. This means that smaller quantities of nanomaterial can carry larger doses of active agents, ensuring that drugs are delivered efficiently to the target site. When combined with ligand-free surfaces and ultra-small particle sizes (<20 nm), this allows precise delivery directly to diseased cells, while reducing exposure to healthy tissue.
THERAPEUTIC ENHANCEMENT ACROSS DISEASES
THERAPEUTIC ENHANCEMENT ACROSS DISEASES
Our nanomaterials are particularly suited to applications where conventional therapies face challenges in targeting intracellular or hard-to-reach diseases:
VIRAL DISEASES: High SSA nanoparticles can carry antiviral agents into infected cells, increasing intracellular drug concentrations, improving efficacy, and reducing the likelihood of resistance.
CANCER THERAPY: Nanoparticles can deliver chemotherapeutics directly to tumours. The high drug-loading capacity allows for higher effective doses at the tumour site while minimising systemic toxicity.
NEUROLOGICAL DISORDERS: Ultra-small, high SSA nanoparticles can cross the blood-brain barrier, carrying therapeutic molecules directly to neurons for conditions such as Alzheimer’s or Parkinson’s disease.
CARDIOVASCULAR AND METABOLIC DISEASES: Nanoparticles can deliver drugs that dissolve blood clots, reduce inflammation, or improve metabolic control, with enhanced bioavailability and sustained release.
INFECTIOUS AND INTRACELLULAR CONDITIONS: By enabling higher drug payloads within a single nanoparticle, treatments for bacterial infections or intracellular pathogens can be more effective, reducing dosage frequency and treatment duration.
WHY NANOARC QUANTUM MATERIALS
WHY NANOARC QUANTUM MATERIALS
NANOARC’s materials combine the features necessary for therapeutic enhancement:
Ligand-free surfaces maximise drug conjugation and functionalisation
Ultra-small size (<20 nm) allows precise cellular targeting and rapid biodistribution
Exceptionally high surface area (SSA up to 703,000 cm²/g) significantly increases drug loading capacity
Biodegradability ensures safe clearance from the body, reducing accumulation and side effects
By providing high SSA ligand-free nanomaterials, NANOARC enables researchers and drug developers to improve the potency, selectivity and safety of therapeutic interventions, turning conventional drugs into more effective nanotherapeutic solutions.
PRODUCTS
PRODUCTS
Payments can be made directly through our website via bank transfer, credit card, cryptocurrency, invoice issuance for a bank transfer.
The Higher the specific surface area (BET) of the nanoparticles, the more effective the nanomaterial and the lower the necessary dose
Products are sold exclusively on our website
SUBSCRIPTION MODEL : Get special rates and free shipping with pre-order purchase subscriptions
QUARTERLY ( 5 % ) | BI-ANNUALLY ( 10 % ) | ANNUALLY ( 15 % )
WE SHIP WORLDWIDE
ZINCENE™ OXIDE | ATOMICALLY - ARCHITECTURED 2D ZINC OXIDE
ZINCENE™ OXIDE | ATOMICALLY - ARCHITECTURED 2D ZINC OXIDE
NANOARCHITECTURE : Atomically thin sheets (< 1nm)
DIMENSIONS : < 1 nm thickness, up to 2 um lateral width
SURFACE AREA (BET) : 635200 cm²/g
COLOUR : Ligand-Free White Powder
DESCRIPTION: Zincene Oxide™ combines the biocompatibility of ZnO with a 2D nanosheet morphology, maximising surface exposure for therapeutic molecules. The extremely high SSA allows up to 10–15× higher payloads than conventional ZnO nanoparticles, enabling highly effective intracellular delivery. 2D geometry enhances cellular interactions and quantum effects increase reactivity for stronger and more precise drug binding.
APPLICATIONS: Cancer therapy, antiviral treatments, intracellular drug delivery, regenerative medicine, high payload nanotherapeutics.
ATOMICALLY - ARCHITECTURED 0D ZINC OXIDE
ATOMICALLY - ARCHITECTURED 0D ZINC OXIDE
NANOARCHITECTURE : < 10 nm spherical nanoparticles
SURFACE AREA (BET) : 415300 cm²/g
COLOUR : Ligand-Free White Nanopowder
DESCRIPTION: NANOARC’s ZnO nanoparticles are a ligand-free, high SSA powder designed to maximise therapeutic molecule loading. Zinc oxide is biocompatible, biodegradable and possesses intrinsic antimicrobial and anticancer properties. The ultra-high surface area enables up to 5–10× more therapeutic molecules to bind compared with conventional nanoparticles, increasing intracellular concentrations and improving drug efficacy. Quantum-scale effects enhance surface reactivity, supporting effective binding and delivery of antiviral, anticancer and intracellular therapeutic agents.
APPLICATIONS: Viral infections, cancer therapy, antibacterial treatments, intracellular drug delivery, nanotherapeutic research.
ATOMICALLY - ARCHITECTURED AURUM
ATOMICALLY - ARCHITECTURED AURUM
NANOARCHITECTURE : < 10 nm (0.01 μm) Spherical Nanoparticles
COLOUR : Ligand-Free Purple-White/Mauve Nanopowder
SURFACE AREA (BET) : ~ 60,000 cm²/g
DESCRIPTION: NANOARC’s gold nanoparticles offer stability, biocompatibility, and quantum-enhanced reactivity in a ligand-free powder form. Despite a lower SSA than other materials, Au’s surface reactivity at ~10 nm allows significant therapeutic molecule conjugation. Gold’s optical and chemical properties further enable imaging and theranostic applications.
THERAPEUTIC ADVANTAGE: Supports intracellular delivery, targeted therapy, and combination imaging–drug strategies. Increased drug payload improves potency for anticancer and antiviral applications.
APPLICATIONS: Cancer therapy, intracellular antiviral delivery, imaging and theranostics, targeted drug research.
MAGNETENE™ | ATOMICALLY - ARCHITECTURED 2D MAGNETITE
MAGNETENE™ | ATOMICALLY - ARCHITECTURED 2D MAGNETITE
NANOARCHITECTURE : Atomically Thin Sheets/Flakes ( < 1 nm Thickness)
SURFACE AREA (BET) : 495,500 cm²/g
COLOUR : Ligand-Free Black/Blackish-Brown Nanopowder
DESCRIPTION: Magnetene™ is a 2D ligand-free powder combining high SSA with magnetic properties. Its exceptional surface area enables 8–12× higher therapeutic molecule loading, while nanoscale quantum effects increase surface reactivity. Magnetic responsiveness allows precise guidance to target tissues, supporting intracellular delivery with minimal systemic exposure.
APPLICATIONS: Targeted cancer therapies, magnetic-guided drug delivery, antiviral research, neurological treatments, imaging-assisted therapeutics.
HAPENE™ | ATOMICALLY - ARCHITECTURED 2D HYDROXYAPATITE
HAPENE™ | ATOMICALLY - ARCHITECTURED 2D HYDROXYAPATITE
NANOARCHITECTURE : Atomically-thin 2D material | < 1 nm (< 0.001 μm) thickness
SURFACE AREA (BET) : 703,000 cm²/g
COLOUR : Ligand-Free White Nanopowder
DESCRIPTION: Hapene™ is an ultra-high SSA, 2D ligand-free hydroxyapatite powder, providing up to 15–20× higher therapeutic payloads than conventional hydroxyapatite nanoparticles. Biocompatible and biodegradable, it supports targeted intracellular delivery, controlled release, and regenerative applications. Quantum-scale surface effects enhance adsorption and drug interaction, increasing efficacy for intracellular and tissue-level therapies.
APPLICATIONS: Bone and tissue regeneration, cancer therapy, cardiovascular and antiviral treatments, controlled drug delivery.
ATOMICALLY - ARCHITECTURED CALCIUM HYDROXIDE
ATOMICALLY - ARCHITECTURED CALCIUM HYDROXIDE
NANOARCHITECTURE : < 25 nm Spherical hollow nanoparticles
SURFACE AREA (BET) : 388000 cm²/g
COLOUR : Ligand-Free White Nanopowder
HEAT RESISTANCE : Up to 580 °C (1076 °F)
DESCRIPTION: Calcium hydroxide nanoparticles provide a high SSA ligand-free platform for therapeutic molecule loading. Biodegradable and ion-releasing, Ca(OH)₂ nanoparticles support tissue interaction while delivering drugs efficiently to intracellular or extracellular targets. High SSA allows up to 6–10× more drug molecules per particle, improving intracellular concentration and treatment efficacy.
APPLICATIONS: Bone and tissue regeneration, targeted cancer therapy, metabolic therapy, intracellular drug delivery, nanotherapeutic research.
Report abuse